Table 2.
Adverse cardiovascular events according to MHR tertiles during follow-up.
| Adverse cardiovascular events | T1: < 7.7 | T2: 7.7–11.3 | T3: > 11.3 | P -value |
|---|---|---|---|---|
| Primary endpoint, n (%) | 80 (14.1) | 121 (20.9) | 152 (26.5) | <0.001 |
| Overall death, n (%) | 6 (1.1) | 20 (3.5) | 18 (3.1) | 0.021 |
| Non-fatal MI, n (%) | 9 (1.6) | 15 (2.6) | 25 (4.5) | 0.017 |
| Non-fatal stroke, n (%) | 6 (1.1) | 8 (1.4) | 11 (1.9) | 0.474 |
| Unplanned repeat revascularization, n (%) | 67 (11.8) | 96 (16.6) | 124 (21.6) | <0.001 |
The primary endpoint was defined as the composite of overall death, non-fatal stroke, non-fatal MI, and unplanned repeat revascularization. MI, myocardial infarction.